Follow The Filings

UMAC Unusual Machines Inc.

Information Technology, filed as UNUSUAL MACHS INC (COM SHS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $6.1M
  • 1 reduce

In 2026 Q2 Davidson Kempner Capital Management trimmed Unusual Machines.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Davidson Kempner Capital Management). Not free-float ownership.

  1. Davidson Kempner Capital Mana... Reduce 0.07%

Who owns UMAC

Sorted by value, long equity only, as of 2026 Q2.

History
Davidson Kempner Capital Management 0.07%, was 0.28% Reduce −83.4% 275,000 $6.1M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by UMAC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All UMAC insider trades
  • None no insider bought on the open market
  • $5.2M sold by 5 insiders outside a trading plan
  • $5.9M sold by 5 insiders under 10b5-1 plans
  1. Brian Joseph Hoff CFO
    Planned sale
    $297K 11,413 shares at $26.01 3.2% of stake
    Traded Aug 20 Filed Aug 21
    ↗
  2. Andrew Ross Camden President
    Planned sale
    $250K 9,625 shares at $26.01 3.9% of stake
    Traded Aug 20 Filed Aug 21
    ↗
  3. Stacy Rochelle Wright Chief Revenue Officer
    Planned sale
    $715K 27,500 shares at $26.00 29% of stake
    Traded Aug 20 Filed Aug 21
    ↗
  4. Jeffrey M Thompson Director
    Sale
    $816K 30,000 shares at $27.19 0.6% of stake
    Traded Jun 5–8 Filed Jun 9
    ↗
  5. Andrew Ross Camden President
    Sale
    $3M 100,000 shares at $30.05 29% of stake
    Traded Jun 4 Filed Jun 5
    ↗
  6. Sanford Rich Director
    Planned sale
    $725K 25,000 shares at $28.98 12% of stake
    Traded Jun 1 Filed Jun 2
    ↗
  7. Brian Joseph Hoff CFO
    Planned sale
    $2.7M 150,000 shares at $17.71 30% of stake
    Traded May 27 Filed May 29
    ↗
  8. Andrew Ross Camden President
    Planned sale
    $136K 9,625 shares at $14.18 2.7% of stake
    Traded May 21 Filed May 22
    ↗
  9. Sanford Rich Director
    Planned sale
    $20K 1,392 shares at $14.18 0.7% of stake
    Traded May 21 Filed May 22
    ↗
  10. Brian Joseph Hoff CFO
    Planned sale
    $162K 11,412 shares at $14.17 2.2% of stake
    Traded May 21 Filed May 22
    ↗
  11. Andrew Ross Camden President
    Planned sale
    $179K 9,625 shares at $18.57 2.6% of stake
    Traded Mar 16 Filed Mar 17
    ↗
  12. Stacy Rochelle Wright Chief Revenue Officer
    Planned sale
    $255K 13,750 shares at $18.57 13% of stake
    Traded Mar 16 Filed Mar 17
    ↗
  13. Brian Joseph Hoff CFO
    Planned sale
    $212K 11,413 shares at $18.59 2.2% of stake
    Traded Mar 16 Filed Mar 17
    ↗
  14. Sanford Rich Director
    Planned sale
    $20K 980 shares at $20.20 0.5% of stake
    Traded Mar 16 Filed Mar 17
    ↗
  15. Sanford Rich Director
    Sale
    $22K 11,087 shares at $1.99 5.1% of stake
    Traded Dec 29, 2025 Filed Dec 31, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 16 stock grants and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
DEF 14A FORM DEF 14A Filing Doc
8-K 4.01,5.03,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q FORM 10-Q FOR JUNE 2026 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 8.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q FOR MAR 2026 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 14 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0M $5.57M $11.2M
Gross profit $0M $1.55M $3.91M
Gross margin * — 27.8% 34.9%
Net income -$2.38M -$31.98M -$19.19M
Net margin * — -574.6% -171.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.02M $6.1M $159.51M
Total non-current assets $0.514M $10.01M $23.2M
Total assets $1.53M $16.11M $182.71M
Total current liabilities $0.114M $0.934M $2.6M
Total non-current liabilities * — $0.356M $5.17M
Total equity $1.41M $14.82M $174.94M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.78M -$4M -$21.18M
Cash from investing -$0.003M -$0.853M -$37.09M
Cash from financing -$0.425M $7.71M $157.77M
Net change in cash * -$2.2M $2.86M $99.5M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.